• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Convatec, Beta Bionics partner on iLet bionic pancreas

May 25, 2023 By Sean Whooley

Beta Bionics iLet Dexcom G6 Convatec infusion set
The iLet Bionic Pancreas with a Dexcom G6 CGM and Convatec infusion set. [Image courtesy of Convatec/Beta Bionics]
Convatec announced that it partnered with Beta Bionics on the launch of the iLet Bionic Pancreas for automated insulin delivery.

FDA last week cleared the Beta Bionics iLet ACE automated insulin pump and iLet dosing decision software.

Convatec offers design and manufacturing services for infusion set technologies and insertion devices for insulin pump treatment. Beta Bionics’ iLet uses its inset and contact detach infusion sets for subcutaneous insulin administration.

The company’s inset, an all-in-one infusion set with a built-in insertion device, connects to iLet on one end and the infusion site at the other. It features a soft, indwelling cannula. Convatec’s contact detach comes with a thin, stainless steel needle. Both infusion sets use kink-free infusion tubing to ensure uninterrupted insulin infusion. They also feature a skin-friendly adhesive tape to secure the set firmly at the infusion site.

Convatec intends to manufacture these sets for Beta Bionics at its production sites in Mexico. The company said it’s “pleased to be part” of the launch of the Beta Bionics offering.

“We are pleased to be a part of the iLet Bionic Pancreas system, a truly innovative offering that provides more choice for people with Type 1 diabetes,” said Kjersti Grimsrud, Convatec COO of infusion care. “Convatec has been committed to pioneering diabetes solutions for more than 30 years. This partnership further demonstrates the strength of Convatec’s technology and leadership in infusion solutions. We are delighted to have Beta Bionics in our line-up of professional insulin pump partners, who share our ethos of providing innovative and simplified medical device solutions to patients and healthcare professionals.”

About the Beta Bionics iLet Bionic Pancreas

The iLet ACE pump and a compatible, FDA-cleared integrated continuous glucose monitor (iCGM), comprise the iLet Bionic Pancreas. Using an algorithm, the automated insulin delivery system determines and commands insulin delivery. iLet currently pairs with the Dexcom G6 CGM.

Beta Bionics’ iLet Bionic Pancreas uses an adaptive, closed-loop algorithm. It initializes with the user’s body weight and requires no additional insulin dosing parameters. The algorithm removes the need to manually adjust insulin pump therapy settings and variables.

iLet simplifies mealtime use by replacing conventional carb counting with its meal announcement feature. This enables users to estimate the amount of carbs in their meal, categorized as “small,” “medium” or “large.” Over time, the algorithm learns to respond to users’ individual insulin needs.

The platform’s dosing decision software determines and commands the increase, decrease, maintenance or suspension of basal insulin doses. It commands correction doses of insulin based on the input from an iCGM and independently determines and commands meal doses of insulin based on the meal announcement feature.

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Beta Bionics, Convatec

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS